CNBC March 16, 2024
Key Points
– The blockbuster weight loss drug Wegovy is now approved in the U.S. for heart health.
– But some health plans and employers are still reluctant to cover Wegovy due to its hefty price tag, which they say could significantly strain their budgets.
– Plans are likely to take notice of Wegovy’s new approval and start considering whether to cover the treatment when they next update their formularies.
In the U.S., Wegovy is no longer just for weight loss.
The blockbuster drug — one of a handful of weight loss treatments to skyrocket in popularity over the last year — is now approved in the U.S. for heart health, too. But that may not translate to wider...
Today's Sponsors
Today's Sponsor